Pharmacology Quiz: General Anesthetics And Sedatives
20 questions · exam conditions
0:00
General Anesthetics And SedativesQuestion 1 of 20

A patient is induced with an agent that primarily acts by potentiating the inhibitory effect of GABA on the GABA-A receptor, increasing the duration of chloride channel opening. Another patient is induced with an agent that primarily acts as a non-competitive antagonist at the NMDA glutamate receptor. Which pair of drugs best represents the first and second agents, respectively?

Propofol, Ketamine
Thiopental, Ketamine
Midazolam, Propofol
Ketamine, Thiopental
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: General Anesthetics And Sedatives

Practice General Anesthetics And Sedatives in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on General Anesthetics And Sedatives, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient is induced with an agent that primarily acts by potentiating the inhibitory effect of GABA on the GABA-A receptor, increasing the duration of chloride channel opening. Another patient is induced with an agent that primarily acts as a non-competitive antagonist at the NMDA glutamate receptor. Which pair of drugs best represents the first and second agents, respectively?

  1. Propofol, Ketamine
  2. Thiopental, Ketamine (correct answer)
  3. Midazolam, Propofol
  4. Ketamine, Thiopental
Explanation: The first description refers to the mechanism of barbiturates (e.g., thiopental), which increase the duration of GABA-A receptor chloride channel opening. This is distinct from benzodiazepines, which increase the frequency of channel opening. The second description refers to ketamine, which is a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor. While propofol also works via the GABA-A receptor, its exact mechanism is complex and differs from the classic barbiturate pattern described.

Question 2

A 70-year-old patient who received midazolam and fentanyl for a procedure is found to have a respiratory rate of 6 breaths/min and an oxygen saturation of 85% on room air. The patient responds only to deep painful stimuli. The team administers naloxone, which improves the respiratory rate to 12 breaths/min, but the patient remains excessively sedated. Which additional medication is indicated to specifically reverse the remaining sedative effects?

  1. An additional dose of naloxone
  2. Flumazenil (correct answer)
  3. Physostigmine
  4. Doxapram
Explanation: This patient received both an opioid (fentanyl) and a benzodiazepine (midazolam). The initial improvement with naloxone indicates reversal of the opioid-induced respiratory depression. However, the persistent sedation is likely due to the effects of midazolam. Flumazenil is a competitive antagonist at the benzodiazepine receptor site on the GABA-A complex and is the specific antidote for benzodiazepine overdose. Physostigmine (an anticholinesterase) and doxapram (a respiratory stimulant) are not specific reversal agents for benzodiazepines.

Question 3

An anesthetic induction is performed using a high concentration of nitrous oxide combined with a low concentration of desflurane. The rapid uptake of large volumes of nitrous oxide from the alveoli into the blood concentrates the remaining desflurane in the alveoli. This phenomenon is known as:

  1. The concentration effect.
  2. Diffusion hypoxia.
  3. The second gas effect. (correct answer)
  4. Meyer-Overton correlation.
Explanation: The second gas effect describes how the rapid uptake of a large volume of one gas (the 'first gas', e.g., nitrous oxide) from the alveoli can increase the alveolar concentration and uptake of a concurrently administered 'second gas' (e.g., desflurane). This concentrating effect accelerates the induction of anesthesia by the second gas. The concentration effect is related but describes how a higher inspired concentration of a single agent can speed its own uptake. Diffusion hypoxia occurs during emergence when nitrous oxide rushes back into the alveoli. The Meyer-Overton correlation relates lipid solubility to potency.

Question 4

A patient is maintained on a stable concentration of sevoflurane for a surgical procedure. The anesthesiologist adds 50% nitrous oxide to the inspired gas mixture while adjusting the sevoflurane vaporizer downward. What is the primary pharmacological principle that justifies this action?

  1. The second gas effect, which increases sevoflurane's partial pressure.
  2. The additive nature of MAC, allowing nitrous oxide to contribute to the total anesthetic depth. (correct answer)
  3. Nitrous oxide's ability to directly antagonize the cardiodepressant effects of sevoflurane.
  4. A significant increase in sevoflurane's oil:gas partition coefficient caused by nitrous oxide.
Explanation: The Minimum Alveolar Concentration (MAC) values of inhaled anesthetics are additive. The MAC of nitrous oxide is approximately 104%, so a 50% concentration (0.5 MAC) contributes significantly to the total anesthetic state. By adding nitrous oxide, the required concentration of the volatile anesthetic (sevoflurane) to achieve 1 MAC can be reduced, which is known as a 'sparing effect'. The second gas effect relates to induction, not maintenance. Nitrous oxide does not antagonize sevoflurane's effects or change its intrinsic physicochemical properties.

Question 5

A 78-year-old male with severe aortic stenosis and a baseline left ventricular ejection fraction of 25% requires emergent endotracheal intubation for respiratory failure. The primary goal during induction is to maintain hemodynamic stability. Which intravenous anesthetic agent would be the most appropriate choice for this patient?

  1. Propofol
  2. Ketamine
  3. Etomidate (correct answer)
  4. Thiopental
Explanation: Etomidate is the most hemodynamically stable of the intravenous induction agents. It causes minimal changes in heart rate, blood pressure, and cardiac output, making it ideal for patients with severe cardiovascular compromise, such as aortic stenosis and poor ventricular function. Propofol and thiopental cause significant myocardial depression and vasodilation, which would likely lead to severe hypotension in this patient. Ketamine is a sympathomimetic and increases heart rate and myocardial oxygen demand, which is detrimental in severe aortic stenosis.

Question 6

A 62-year-old patient complains of difficulty falling asleep but denies issues with staying asleep. The patient expresses concern about the risk of daytime sedation and developing tolerance. Which agent would be a rational choice due to its selective agonism at the α1 subunit of the GABA-A receptor complex, which primarily mediates sedation, and its relatively short duration of action?

  1. Diazepam
  2. Phenobarbital
  3. Zolpidem (correct answer)
  4. Ramelteon
Explanation: Zolpidem is a non-benzodiazepine hypnotic ('Z-drug') that exhibits relative selectivity for the α1 subunit of the GABA-A receptor. This subunit is thought to be responsible for sedative effects, whereas α2 and α3 subunits are linked to anxiolytic and muscle relaxant effects. Its short half-life makes it ideal for sleep-onset insomnia with less risk of next-day sedation compared to longer-acting, non-selective agents like diazepam. Phenobarbital is a barbiturate with a high potential for tolerance and side effects. Ramelteon acts on melatonin receptors, a different mechanism.

Question 7

A key difference in the mechanism of action between barbiturates and benzodiazepines at the GABA-A receptor explains the lower therapeutic index of barbiturates. Which statement accurately describes this difference?

  1. At high concentrations, barbiturates can directly activate the GABA-A receptor in the absence of GABA. (correct answer)
  2. Barbiturates are competitive antagonists of GABA, while benzodiazepines are positive allosteric modulators.
  3. Benzodiazepines increase the duration of chloride channel opening, while barbiturates increase the frequency.
  4. Only benzodiazepines bind to the GABA-A receptor; barbiturates act on voltage-gated sodium channels.
Explanation: When you encounter questions about GABA-A receptor pharmacology, focus on understanding how different drug classes modulate this critical inhibitory receptor system and why their safety profiles differ so dramatically. The key mechanistic difference lies in how these drugs interact with the GABA-A receptor at high concentrations. Barbiturates have a unique and dangerous property: at sufficient concentrations, they can directly open the chloride channel even without GABA present. This direct activation bypasses the normal physiological controls and can lead to profound CNS depression, respiratory failure, and death. Benzodiazepines, in contrast, are pure positive allosteric modulators—they can only enhance GABA's effects when GABA is already present, providing a built-in safety mechanism. This explains why barbiturates have such a narrow therapeutic index and why benzodiazepines largely replaced them clinically. Looking at the incorrect options: B reverses the mechanisms entirely—barbiturates aren't competitive antagonists, and the benzodiazepine description, while correct, misses the critical point. C confuses the mechanistic details—both drugs affect chloride channel kinetics, but this doesn't explain the safety difference. D is completely wrong; both drug classes act on GABA-A receptors, and barbiturates don't primarily target sodium channels. Remember this safety principle: drugs that can bypass normal physiological controls (like barbiturates directly activating GABA-A receptors) typically have much narrower therapeutic windows than drugs that only modulate existing signaling (like benzodiazepines requiring GABA to be present).

Question 8

A patient in the surgical ICU requires light sedation that allows for periods of wakefulness for neurological examination. An infusion of dexmedetomidine is chosen. Which statement best describes the primary mechanism of action and a key clinical feature of this agent?

  1. It is a selective central α2-adrenergic agonist that produces sedation with minimal respiratory depression. (correct answer)
  2. It is a GABA-A receptor modulator that causes profound amnesia and significant dose-dependent apnea.
  3. It is an NMDA receptor antagonist that provides analgesia but often causes emergence hallucinations.
  4. It is a melatonin receptor agonist that primarily regulates the sleep-wake cycle with no analgesic properties.
Explanation: Dexmedetomidine is a selective α2-adrenergic agonist that acts on receptors in the locus coeruleus of the brainstem to produce sedation and analgesia. A key advantage is that it does not cause significant respiratory depression, unlike opioids and GABAergic agents. The sedation it produces is often described as 'cooperative' or 'arousable,' making it ideal for situations requiring patient interaction, such as neurological assessments.

Question 9

The oil:gas partition coefficient of an inhaled anesthetic correlates strongly with its potency. Agent A has an oil:gas partition coefficient of 1,900 and a MAC of 0.75%. Agent B is a new experimental agent with an oil:gas partition coefficient of 230. Based on the Meyer-Overton correlation, what is the most likely predicted MAC for Agent B?

  1. 0.09%
  2. 0.75%
  3. 6.2% (correct answer)
  4. 12.5%
Explanation: Potency is inversely proportional to MAC and directly proportional to the oil:gas partition coefficient (lipid solubility). We can set up a ratio: (Potency A / Potency B) = (Oil:Gas A / Oil:Gas B). Since Potency is proportional to 1/MAC, this becomes (MAC B / MAC A) = (Oil:Gas A / Oil:Gas B). Plugging in the values: (MAC B / 0.75%) = (1900 / 230). (MAC B / 0.75%) ≈ 8.26. MAC B ≈ 0.75% * 8.26 ≈ 6.2%. Agent B is much less lipid-soluble, so it will be much less potent, requiring a higher MAC.

Question 10

A new volatile anesthetic, Agent X, has a blood:gas partition coefficient of 0.4. A second agent, Agent Y, has a blood:gas partition coefficient of 1.4. Assuming all other factors such as ventilation and cardiac output are equal, which statement most accurately describes the expected difference in the rate of anesthetic induction?

  1. Induction with Agent X will be more rapid because its lower solubility in blood allows for a faster rise in alveolar partial pressure. (correct answer)
  2. Induction with Agent Y will be more rapid because its higher solubility allows it to be carried away from the lungs more efficiently.
  3. Induction speed will be similar for both agents, but Agent X will be significantly more potent than Agent Y.
  4. Induction with Agent X will be slower because a larger volume of the agent must be delivered to saturate the blood before equilibrium is reached.
Explanation: The blood:gas partition coefficient is a measure of an inhaled anesthetic's solubility in the blood. A lower coefficient (like Agent X's 0.4) indicates lower solubility. This means less anesthetic is taken up by the blood passing through the lungs, allowing the partial pressure in the alveoli (and subsequently, the brain) to rise more quickly, resulting in a faster induction of anesthesia. A higher coefficient (like Agent Y's 1.4) means more anesthetic dissolves in the blood, slowing the rise in alveolar partial pressure and leading to a slower induction.

Question 11

A 78-year-old male with severe aortic stenosis and a baseline left ventricular ejection fraction of 25% requires emergent endotracheal intubation for respiratory failure. The primary goal during induction is to maintain hemodynamic stability. Which intravenous anesthetic agent would be the most appropriate choice for this patient?

  1. Propofol
  2. Ketamine
  3. Etomidate (correct answer)
  4. Thiopental
Explanation: Etomidate is the most hemodynamically stable of the intravenous induction agents. It causes minimal changes in heart rate, blood pressure, and cardiac output, making it ideal for patients with severe cardiovascular compromise, such as aortic stenosis and poor ventricular function. Propofol and thiopental cause significant myocardial depression and vasodilation, which would likely lead to severe hypotension in this patient. Ketamine is a sympathomimetic and increases heart rate and myocardial oxygen demand, which is detrimental in severe aortic stenosis.

Question 12

A patient is maintained on a stable concentration of sevoflurane for a surgical procedure. The anesthesiologist adds 50% nitrous oxide to the inspired gas mixture while adjusting the sevoflurane vaporizer downward. What is the primary pharmacological principle that justifies this action?

  1. The second gas effect, which increases sevoflurane's partial pressure.
  2. The additive nature of MAC, allowing nitrous oxide to contribute to the total anesthetic depth. (correct answer)
  3. Nitrous oxide's ability to directly antagonize the cardiodepressant effects of sevoflurane.
  4. A significant increase in sevoflurane's oil:gas partition coefficient caused by nitrous oxide.
Explanation: The Minimum Alveolar Concentration (MAC) values of inhaled anesthetics are additive. The MAC of nitrous oxide is approximately 104%, so a 50% concentration (0.5 MAC) contributes significantly to the total anesthetic state. By adding nitrous oxide, the required concentration of the volatile anesthetic (sevoflurane) to achieve 1 MAC can be reduced, which is known as a 'sparing effect'. The second gas effect relates to induction, not maintenance. Nitrous oxide does not antagonize sevoflurane's effects or change its intrinsic physicochemical properties.

Question 13

A patient is induced with an agent that primarily acts by potentiating the inhibitory effect of GABA on the GABA-A receptor, increasing the duration of chloride channel opening. Another patient is induced with an agent that primarily acts as a non-competitive antagonist at the NMDA glutamate receptor. Which pair of drugs best represents the first and second agents, respectively?

  1. Propofol, Ketamine
  2. Thiopental, Ketamine (correct answer)
  3. Midazolam, Propofol
  4. Ketamine, Thiopental
Explanation: The first description refers to the mechanism of barbiturates (e.g., thiopental), which increase the duration of GABA-A receptor chloride channel opening. This is distinct from benzodiazepines, which increase the frequency of channel opening. The second description refers to ketamine, which is a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor. While propofol also works via the GABA-A receptor, its exact mechanism is complex and differs from the classic barbiturate pattern described.

Question 14

A 70-year-old patient who received midazolam and fentanyl for a procedure is found to have a respiratory rate of 6 breaths/min and an oxygen saturation of 85% on room air. The patient responds only to deep painful stimuli. The team administers naloxone, which improves the respiratory rate to 12 breaths/min, but the patient remains excessively sedated. Which additional medication is indicated to specifically reverse the remaining sedative effects?

  1. An additional dose of naloxone
  2. Flumazenil (correct answer)
  3. Physostigmine
  4. Doxapram
Explanation: This patient received both an opioid (fentanyl) and a benzodiazepine (midazolam). The initial improvement with naloxone indicates reversal of the opioid-induced respiratory depression. However, the persistent sedation is likely due to the effects of midazolam. Flumazenil is a competitive antagonist at the benzodiazepine receptor site on the GABA-A complex and is the specific antidote for benzodiazepine overdose. Physostigmine (an anticholinesterase) and doxapram (a respiratory stimulant) are not specific reversal agents for benzodiazepines.

Question 15

A 35-year-old patient with a severe head injury has been sedated in the ICU with a propofol infusion at 5 mg/kg/hr for four days. The patient develops unexplained metabolic acidosis, hypertriglyceridemia, bradycardia leading to asystole, and an elevated creatine kinase. This clinical presentation is most consistent with which iatrogenic complication?

  1. Neuroleptic malignant syndrome
  2. Serotonin syndrome
  3. Malignant hyperthermia
  4. Propofol infusion syndrome (PRIS) (correct answer)
Explanation: Propofol infusion syndrome (PRIS) is a rare but life-threatening complication associated with high-dose (>4 mg/kg/hr) and prolonged (>48 hours) infusions of propofol. It is characterized by severe metabolic acidosis, rhabdomyolysis (elevated CK), hyperlipidemia, and cardiovascular collapse (bradycardia, arrhythmia). The other choices are distinct syndromes with different triggers (antipsychotics for NMS, serotonergic agents for SS, volatile anesthetics/succinylcholine for MH) and clinical features.

Question 16

A key difference in the mechanism of action between barbiturates and benzodiazepines at the GABA-A receptor explains the lower therapeutic index of barbiturates. Which statement accurately describes this difference?

  1. At high concentrations, barbiturates can directly activate the GABA-A receptor in the absence of GABA. (correct answer)
  2. Barbiturates are competitive antagonists of GABA, while benzodiazepines are positive allosteric modulators.
  3. Benzodiazepines increase the duration of chloride channel opening, while barbiturates increase the frequency.
  4. Only benzodiazepines bind to the GABA-A receptor; barbiturates act on voltage-gated sodium channels.
Explanation: When you encounter questions about GABA-A receptor pharmacology, focus on understanding how different drug classes modulate this critical inhibitory receptor system and why their safety profiles differ so dramatically. The key mechanistic difference lies in how these drugs interact with the GABA-A receptor at high concentrations. Barbiturates have a unique and dangerous property: at sufficient concentrations, they can directly open the chloride channel even without GABA present. This direct activation bypasses the normal physiological controls and can lead to profound CNS depression, respiratory failure, and death. Benzodiazepines, in contrast, are pure positive allosteric modulators—they can only enhance GABA's effects when GABA is already present, providing a built-in safety mechanism. This explains why barbiturates have such a narrow therapeutic index and why benzodiazepines largely replaced them clinically. Looking at the incorrect options: B reverses the mechanisms entirely—barbiturates aren't competitive antagonists, and the benzodiazepine description, while correct, misses the critical point. C confuses the mechanistic details—both drugs affect chloride channel kinetics, but this doesn't explain the safety difference. D is completely wrong; both drug classes act on GABA-A receptors, and barbiturates don't primarily target sodium channels. Remember this safety principle: drugs that can bypass normal physiological controls (like barbiturates directly activating GABA-A receptors) typically have much narrower therapeutic windows than drugs that only modulate existing signaling (like benzodiazepines requiring GABA to be present).

Question 17

A 19-year-old male receives an intravenous anesthetic for the reduction of a dislocated shoulder. In the recovery room, he becomes agitated and describes seeing 'terrifying colors and patterns' and feeling disconnected from his body. Co-administration of which type of drug during anesthesia is known to reduce the incidence of this adverse effect?

  1. An opioid, such as fentanyl
  2. A benzodiazepine, such as midazolam (correct answer)
  3. A non-steroidal anti-inflammatory drug
  4. An antiemetic, such as ondansetron
Explanation: The symptoms described (hallucinations, agitation, dissociative feelings) are characteristic of an emergence reaction from ketamine. These psychomimetic effects are a well-known side effect. Co-administration of a benzodiazepine, such as midazolam or diazepam, can attenuate or prevent these emergence reactions by providing anxiolysis and amnesia through GABA-A receptor modulation.

Question 18

A 25-year-old patient with multiple traumatic injuries is hypotensive (BP 85/50 mmHg) and requires procedural sedation for closed reduction of a femur fracture in the emergency department. Which agent is often preferred in this setting due to its ability to produce profound analgesia and amnesia while maintaining or increasing cardiovascular parameters?

  1. Midazolam
  2. Propofol
  3. Ketamine (correct answer)
  4. Dexmedetomidine
Explanation: Ketamine is unique among anesthetics in that it has sympathomimetic properties, typically increasing heart rate, blood pressure, and cardiac output. It also produces a state of 'dissociative anesthesia,' providing intense analgesia and amnesia. This makes it an excellent choice for hemodynamically unstable patients, such as this trauma patient. Propofol would cause further hypotension. Midazolam can cause vasodilation and hypotension. Dexmedetomidine can cause bradycardia and hypotension, making it less ideal in this acute trauma setting.

Question 19

During a laparotomy, a patient anesthetized with isoflurane and succinylcholine develops a rapid increase in end-tidal CO2, muscle rigidity, tachycardia, and hyperthermia. Malignant hyperthermia is suspected. Beyond discontinuing triggering agents, which intervention directly addresses the underlying pathophysiological mechanism of this crisis?

  1. Administration of intravenous verapamil to block calcium influx.
  2. Administration of sodium bicarbonate to correct metabolic acidosis.
  3. Administration of a non-depolarizing muscle relaxant like rocuronium.
  4. Administration of dantrolene to block calcium release from the sarcoplasmic reticulum. (correct answer)
Explanation: Malignant hyperthermia is caused by uncontrolled calcium release from the sarcoplasmic reticulum (SR) in skeletal muscle, mediated by a dysfunctional ryanodine receptor (RyR1). Dantrolene is the specific antidote that acts by binding to the RyR1 receptor and inhibiting this calcium release. While sodium bicarbonate is used to treat the resulting acidosis, it is a supportive measure, not a treatment for the root cause. Verapamil is contraindicated as it can cause life-threatening hyperkalemia when given with dantrolene. Rocuronium works at the neuromuscular junction and will not stop the ongoing calcium release within the muscle cell.

Question 20

A patient with insomnia is prescribed suvorexant. This medication improves sleep by a novel mechanism that differs from traditional hypnotics like benzodiazepines and zolpidem. Suvorexant exerts its therapeutic effect by which of the following mechanisms?

  1. Potentiating the effects of GABA at the GABA-A receptor
  2. Acting as an agonist at MT1 and MT2 melatonin receptors
  3. Antagonizing H1 histamine receptors in the central nervous system
  4. Blocking OX1 and OX2 orexin receptors to suppress wakefulness (correct answer)
Explanation: Suvorexant is a dual orexin receptor antagonist (DORA). The orexin system (orexin A and B) is a key central promoter of wakefulness. By blocking orexin receptors (OX1R and OX2R), suvorexant suppresses the wake drive, thereby promoting the initiation and maintenance of sleep. This mechanism is distinct from GABA-A modulators (benzodiazepines), melatonin agonists (ramelteon), or histamine antagonists (doxylamine).